FDA Approved: MYALEPT — Original Application (Chiesi USA, Inc.)

View source ↗

Summary

This FDA overview documents the original approval of MYALEPT (metreleptin) by Chiesi USA, for leptin deficiency in patients with generalized lipodystrophy. It c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Generalized Lipodystrophy
• Congenital Generalized Lipodystrophy

Drugs mentioned

• MYALEPT (METRELEPTIN)

Snippet

ORIG AP for MYALEPT (METRELEPTIN)